The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
about
Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalisCannabis and psychiatric disorders: it is not only addictionThe endocannabinoid system as a target for the treatment of cannabis dependenceThe endocannabinoid system as an emerging target of pharmacotherapyRab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learningTranslational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorderPTSD: from neurobiology to pharmacological treatmentsElevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study50 years of hurdles and hope in anxiolytic drug discoveryEndocannabinoid-mediated synaptic plasticity and addiction-related behaviorDevelopmental regulation of fear learning and anxiety behavior by endocannabinoids.The effects of infusions of CART 55-102 into the basolateral amygdala on amphetamine-induced conditioned place preference in rats.Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies.Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats.Recent progress in understanding the pathophysiology of post-traumatic stress disorder: implications for targeted pharmacological treatment.Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.The clinical implications of mouse models of enhanced anxiety.Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy.Endocannabinoid signaling in the etiology and treatment of major depressive illness.Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats.Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in miceA role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors.Clinical applications of hallucinogens: A review.Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient miceThe endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effectsCognitive enhancers for anxiety disorders.The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus.Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in ratsAlterations in corticolimbic dendritic morphology and emotional behavior in cannabinoid CB1 receptor-deficient mice parallel the effects of chronic stress.Effects of endocannabinoid system modulation on cognitive and emotional behaviorChronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats.Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.The individuality of mice.
P2860
Q21142667-A8733ABF-9660-42AD-BC00-E4D58149BBADQ22242611-5A35D907-FE6B-4660-9E81-99A6A94658B2Q24648135-8DAF209B-CF90-43B0-8952-0AB02CDFC6F7Q24648473-A7ABFFBA-3331-42CB-B499-8B52D87FB601Q26269894-4595BD1A-A8FA-43A8-900B-EF983F9DC46DQ27026926-AA0D0FBE-A485-4F74-A1CA-7D156623845AQ28070159-608740D9-4820-4DC7-89BC-4825C5D514FBQ28290553-9A46844D-A952-44FE-AF2E-5CF53FC32D26Q28297569-FDC230A5-9F36-4E3B-A769-153A56B5DF75Q29042501-2C53A4EA-C714-4A31-B644-3D7F207A4788Q30366747-98972249-B692-4171-83E0-12B8D361A6D6Q30383960-2FD75BC1-F472-4B0E-A927-EDDF04F676A0Q30430922-6775D76B-62B6-4D35-AB29-20EA2D60F6FBQ30437947-D6FC1735-9D8E-45F6-B002-6E17097C65D0Q30442231-6C44AE58-8D74-4EA9-91D7-D4C820FC8E8AQ30471167-7F6EAF4D-4359-439F-890A-0CB34F03770BQ30473707-86C3993C-12A9-48E8-8B58-0DB1ACBA3E4FQ30474232-4CC08A9B-0066-4CAD-8501-94112A962A09Q30480038-018D3A3B-DD07-49ED-9F49-6515D927170EQ30687668-8F29B994-2657-4829-8499-B79552BB748AQ33635704-FFD4FBDE-54E6-44C0-9BC2-8F1B523DA828Q33716706-5D3857F7-BD6E-46F0-B581-2264D262125AQ33804240-BDB7BC1F-1CED-4586-9DCF-CA24661EE85EQ33839407-E9F81537-DA1E-4FE0-BF65-83D588819D78Q34098397-37CE0777-4751-4F2D-BEA0-11858E107BCBQ34535259-1924E5EC-4B38-46B3-8D93-2A3E56B21A4AQ34608846-757835CD-5F7A-412F-B5CC-E83E42AF0C20Q34626755-2EB70B7A-43B3-42C9-BFBA-3C20941CA8B1Q34946680-A23CB754-B439-46C8-BF5A-EE7A45DFB477Q35043125-F0C9CB65-46AD-447A-AA1B-84F6CB177FA3Q35072848-9FF38A57-8937-42FF-9F95-05E36AC0C561Q35119719-8BBF669E-192D-4167-98E7-FE05D93B8A99Q35162864-B023DDDA-0D5E-472C-B4C2-DE6AF6B68BD0Q35209678-2977146E-8003-4C8C-886E-D76068F5BD99Q35219200-0C8560C4-FB63-4ED2-B3CE-C6C753C4566BQ35532072-1D10B8AA-AE74-41BE-931E-BB21FE382F64Q35586638-6480E4F7-F5E1-4138-BDF2-CCFFF7AD5130Q35815567-028D4DF5-2C9E-4578-8F68-0BD54DBA440DQ35839753-C95F0361-C48B-4AD2-82A4-A6F2DC0E0422Q35950530-63C33918-ED1C-40BB-94A7-4A9505FC37DF
P2860
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
The effects of genetic and pha ...... nnabinoid receptor on anxiety.
@en
The effects of genetic and pha ...... nnabinoid receptor on anxiety.
@nl
type
label
The effects of genetic and pha ...... nnabinoid receptor on anxiety.
@en
The effects of genetic and pha ...... nnabinoid receptor on anxiety.
@nl
prefLabel
The effects of genetic and pha ...... nnabinoid receptor on anxiety.
@en
The effects of genetic and pha ...... nnabinoid receptor on anxiety.
@nl
P2093
P2860
P921
P1476
The effects of genetic and pha ...... annabinoid receptor on anxiety
@en
P2093
P2860
P304
P356
10.1046/J.1460-9568.2002.02192.X
P407
P577
2002-10-01T00:00:00Z